請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16547
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭明良 | |
dc.contributor.author | Ming-Hsun Wu | en |
dc.contributor.author | 吳明勳 | zh_TW |
dc.date.accessioned | 2021-06-07T18:20:08Z | - |
dc.date.copyright | 2012-03-02 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-01-10 | |
dc.identifier.citation | 1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide: IARC press 2004.
2. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002; 13: 135-41. 3. Jonjic N, Peri G, Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165-74. 4. Colombo N, Peccatori F, Paganin C, et al. Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy. International journal of cancer 1992; 51: 42-6. 5. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254-65. 6. Nakayama Y, Nagashima N, Minagawa N, et al. Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res 2002; 22: 4291-6. 7. Ohno S, Inagawa H, Dhar DK, et al. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 2003; 23: 5015-22. 8. Hiratsuka S, Nakamura K, Iwai S, et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002; 2: 289-300. 9. Cassatella MA, Gasperini S, Russo MP. Cytokine expression and release by neutrophils. Ann N Y Acad Sci 1997; 832: 233-42. 10. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 17: 2115-7. 11. Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. Journal of mammary gland biology and neoplasia 2002; 7: 177-89. 12. Ogmundsdottir HM, Petursdottir I, Gudmundsdottir I. Interactions between the immune system and breast cancer. Acta Oncol 1995; 34: 647-50. 13. Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res 2003; 36: 433-46. 14. Wahle KW, Rotondo D. Fatty acids and endothelial cell function: regulation of adhesion molecule and redox enzyme expression. Curr Opin Clin Nutr Metab Care 1999; 2: 109-15. 15. Makhoul Z, Kristal AR, Gulati R, et al. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am J Clin Nutr; 91: 777-85. 16. Armstrong VT, Brzustowicz MR, Wassall SR, Jenski LJ, Stillwell W. Rapid flip-flop in polyunsaturated (docosahexaenoate) phospholipid membranes. Arch Biochem Biophys 2003; 414: 74-82. 17. Senkal M, Geier B, Hannemann M, et al. Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr 2007; 31: 12-7. 18. Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006; 9: 140-8. 19. Mascioli E, Leader L, Flores E, Trimbo S, Bistrian B, Blackburn G. Enhanced survival to endotoxin in guinea pigs fed IV fish oil emulsion. Lipids 1988; 23: 623-5. 20. Tsekos E, Reuter C, Stehle P, Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 2004; 23: 325-30. 21. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805-14. 22. Jump DB, Clarke SD, Thelen A, Liimatta M. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 1994; 35: 1076-84. 23. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Bmj 2006; 332: 752-60. 24. Rose DP, Connolly JM. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 2000; 37: 119-27. 25. Fukunaga K, Hossain Z, Takahashi K. Marine phosphatidylcholine suppresses 1,2-dimethylhydrazine-induced colon carcinogenesis in rats by inducing apoptosis. Nutr Res 2008; 28: 635-40. 26. Connolly JM, Rose DP. Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett 1998; 132: 107-12. 27. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501. 28. Chiu LC, Wan JM. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett 1999; 145: 17-27. 29. Narayanan BA, Narayanan NK, Reddy BS. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 2001; 19: 1255-62. 30. Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, Shi YE. Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 2000; 60: 6482-7. 31. Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114: 623-33. 32. Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, Balkwill FR. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 2003; 63: 8360-5. 33. Lee SE, Lim JW, Kim H. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann N Y Acad Sci 2009; 1171: 163-9. 34. Yessoufou A, Ple A, Moutairou K, Hichami A, Khan NA. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J Lipid Res 2009; 50: 2377-88. 35. Dupont IE, Carpentier YA. Clinical use of lipid emulsions. Curr Opin Clin Nutr Metab Care 1999; 2: 139-45. 36. Chen JJ, Lin YC, Yao PL, et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005; 23: 953-64. 37. Ciriza J, Garcia-Ojeda ME. Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development. Stem Cell Res Ther 2010; 1: 14. 38. Ivanoff A, Ivanoff J, Hultenby K, Sundqvist KG. Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1). Clin Exp Metastasis 1999; 17: 695-711. 39. Batetta B, Griinari M, Carta G, et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 2009; 139: 1495-501. 40. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40. 41. Hayakawa K, Meng Y, Hiramatsu N, et al. Priming of glomerular mesangial cells by activated macrophages causes blunted responses to proinflammatory stimuli. J Immunol 2006; 176: 2529-37. 42. Xie G, Cheng K, Shant J, Raufman JP. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 2009; 296: G755-63. 43. Zhang X, Yin P, Di D, et al. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line. Anticancer Res 2009; 29: 4497-501. 44. Ishigami S, Natsugoe S, Tokuda K, et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 2003; 23: 4079-83. 45. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 727-40. 46. Abraham D, Zins K, Sioud M, et al. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. Int J Cancer; 126: 1339-52. 47. Pittet MJ. Behavior of immune players in the tumor microenvironment. Curr Opin Oncol 2009; 21: 53-9. 48. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004; 25: 1543-9. 49. Moghaddami N, Irvine J, Gao X, et al. Novel action of n-3 polyunsaturated fatty acids: inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases. Arthritis Rheum 2007; 56: 799-808. 50. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61: 345-58. 51. Gonzalez MJ. Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr 1995; 14: 325-35. 52. Tuller ER, Beavers CT, Lou JR, Ihnat MA, Benbrook DM, Ding WQ. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol 2009; 76: 588-95. 53. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Laye S. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 2008; 105: 296-307. 54. Lee JY, Plakidas A, Lee WH, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003; 44: 479-86. 55. Wu CY, Chi PL, Hsieh HL, Luo SF, Yang CM. TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: Roles of cytosolic phospholipase A(2)alpha/cyclooxygenase-2. J Cell Physiol 2010; 223: 480-91. 56. Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172: 214-8. 57. McCarty MF. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med Hypotheses 1996; 46: 107-15. 58. Bing RJ, Miyataka M, Rich KA, et al. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 2001; 7: 3385-92. 59. Wen B, Deutsch E, Opolon P, et al. n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer 2003; 89: 1102-7. 60. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135-49. 61. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-39. 62. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P. Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 2009; 458: 1103-14. 63. Wilkins-Port CE, Higgins PJ. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 2007; 185: 116-22. 64. Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA, Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 1993; 268: 17341-7. 65. Madlener M, Mauch C, Conca W, Brauchle M, Parks WC, Werner S. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 1996; 320 ( Pt 2): 659-64. 66. Muller D, Breathnach R, Engelmann A, et al. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991; 48: 550-6. 67. Mathew R, Khanna R, Kumar R, Mathur M, Shukla NK, Ralhan R. Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 2002; 26: 222-8. 68. Sharma R, Chattopadhyay TK, Mathur M, Ralhan R. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology 2004; 67: 300-9. 69. Thorns V, Walter GF, Thorns C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 2003; 23: 3937-44. 70. Bodey B, Bodey B, Jr., Siegel SE, Kaiser HE. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas. Anticancer Res 2000; 20: 4585-90. 71. Aung PP, Oue N, Mitani Y, et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2006; 25: 2546-57. 72. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 1998; 253: 67-75. 73. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 1996; 69: 9-16. 74. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998; 79: 187-94. 75. Steele MM, Schieler AM, Kelley PM, Tempero RM. beta1 integrin regulates MMP-10 dependant tubulogenesis in human lymphatic endothelial cells. Matrix Biol; 30: 218-24. 76. Heo SH, Choi YJ, Ryoo HM, Cho JY. Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. J Cell Physiol; 224: 734-42. 77. Uttamsingh S, Bao X, Nguyen KT, et al. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008; 27: 2626-34. 78. Fang JH, Zhou HC, Zeng C, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion and metastasis by regulating MMP-2 expression. Hepatology. 79. Osaki M, Takeshita F, Sugimoto Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther; 19: 1123-30. 80. Rechardt O, Elomaa O, Vaalamo M, et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000; 115: 778-87. 81. Cho NH, Hong KP, Hong SH, Kang S, Chung KY, Cho SH. MMP expression profiling in recurred stage IB lung cancer. Oncogene 2004; 23: 845-51. 82. Gill JH, Kirwan IG, Seargent JM, et al. MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 2004; 6: 777-85. 83. Krampert M, Bloch W, Sasaki T, et al. Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 2004; 15: 5242-54. 84. Kim D, Kim S, Koh H, et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 2001; 15: 1953-62. 85. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-85. 86. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003; 22: 395-403. 87. Lu MK, Shih YW, Chang Chien TT, Fang LH, Huang HC, Chen PS. alpha-Solanine inhibits human melanoma cell migration and invasion by reducing matrix metalloproteinase-2/9 activities. Biol Pharm Bull; 33: 1685-91. 88. Itoh M, Murata T, Suzuki T, et al. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 2006; 25: 1195-204 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16547 | - |
dc.description.abstract | 攝取二十二碳六烯酸 (docosahexenoic acid, DHA)與二十碳五烯酸 (eicosapentaenoic acid, EPA) 已知與減低癌症發生率,降低癌症相關巨噬細胞 (tumor associated macrophage, TAM) 之數量有關,然而,目前尚未清楚了解其調控機制。
實驗結果發現,巨噬細胞可以增加胃癌細胞的轉移能力。利用聚合酶鏈鎖反應陣列發現巨噬細胞誘導胃癌細胞N87後質金屬蛋白酶(MMP1、MMP3與MMP10)基因表現量顯著上升。而DHA與EPA可抑制巨噬細胞所誘導的癌細胞轉移能力並降低其MMP10的表現,從核醣核酸(RNA)與蛋白質層面均獲得證實。我們也進一步利用zymography與抗體中和實驗得到驗證;另一方面,我們也證實DHA與EPA是藉由降低胃癌細胞的訊息傳遞分子ERK (extracellular signal regulated kinases)與STAT3 (signal transducers and activators of transcription 3) 表現量,進而降低MMP10的表現。 根據上述實驗結果,巨噬細胞會藉由磷酸化ERK與STAT3並增加MMP10的表現量,進而增加胃癌細胞的轉移能力;相反地,加入DHA 與EPA後會降低MMP10的表現。這些發現不但解釋了DHA與EPA的益處與效果,並且指出ERK / STAT3 / MMP10對於胃癌的治療,提供一個可能的治療標的。 | zh_TW |
dc.description.abstract | Uptake of docosahexenoic acid (DHA)/eicosapentaenoic acid (EPA) improves the treatment of cancer and reduces tumor associated macrophage (TAM) count. However, the mechanism of this relationship is still unclear.
In this study, macrophages enhanced gastric cancer cell migration ability and induced the differentially expressed matrix metalloproteinase genes (MMP1, MMP3, and MMP10) of N87 as identified by PCR array. Furthermore, DHA and EPA inhibited macrophage-enhanced cancer cell migration and attenuated MMP10 both at the RNA and protein level. The suppression of MMP10 expression was further verified by zymography and antibody blocking experiments. Additionally, DHA and EPA attenuated expression of macrophage-activated extracellular signal regulated kinases (ERK) and signal transducers and activators of transcription 3 (STAT3) in cancer cells. Attenuation was verified by demonstrating blockade with specific inhibitors, and thereby increased MMP10 expression. Accordingly, we hypothesized that macrophage enhances cancer cell migration through ERK and STAT3 phosphorylation and subsequent increased MMP10 expression and that DHA and EPA could attenuate these signals. These findings not only explain the beneficial effects of DHA/EPA, but also point to ERK/STAT3/MMP10 as the potential targets for gastric cancer treatment. | en |
dc.description.provenance | Made available in DSpace on 2021-06-07T18:20:08Z (GMT). No. of bitstreams: 1 ntu-101-D94447005-1.pdf: 1619761 bytes, checksum: ba66b1a6642f08ff58d3399f03e5072e (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書
誌謝 中文摘要 ......................................... i 英文摘要 ........................................ ii 1. introduction................................. 1 1.1 Gastric cancer ............................. 1 1.2 Tumor associated macrophage ................ 1 1.3 Fish oil ................................... 3 1.4 Omega-3 fatty acids: implications for the treatment of tumor-associated inflammation .................. 4 1.5 Relationship between gastric cancer and fish oil ................................................ 6 2. Material and methods ........................ 6 2.1 Patients and Specimens ..................... 6 2.2 Monoclonal antibodies and immunohistochemistry ................................................ 7 2.3 Cell Culture ............................... 7 2.4 In vitro migration assay ................... 8 2.5 Cell viability assay ....................... 8 2.6 RNA extraction, PCR array, and RT-PCR ...... 9 2.7 Western blot analysis ...................... 9 2.8 Zymography ................................ 10 2.9 Statistical Analysis ...................... 10 3. Results .................................... 11 3.1 Correlation of Immunohistochemical Variables with Clinicopathologic Features in gastric cancer patients ............................................... 11 3.2 Macrophage induces gastric cancer cell migration ............................................... 11 3.3 PCR array identified differentially expressed genes of N87 cells after coculture with macrophage ..... 11 3.4 DHA and EPA inhibited migration of N87 cells ............................................... 12 3.5 DHA and EPA inhibit macrophage-activated cell migration by downregulation of MMP10 .................... 12 3.6 DHA- and EPA-mediated decrease in MMP10 expression might lead to the downregulation of the ERK and STAT3 pathways ................................................13 4. Discussion ................................. 14 5. Tables...................................... 18 6. Figures and figure legends ................. 19 7. References ................................. 33 | |
dc.language.iso | en | |
dc.title | DHA及EPA抑制巨噬細胞誘導胃癌細胞轉移能力之機轉研究 | zh_TW |
dc.title | Mechanism of Docosahexaenoic Acid and Eicosapentaenoic Acid Inhibiting Macrophage-Induced Gastric Cancer Cell Migration | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 林明燦,吳明賢,葉松鈴,王朝鐘 | |
dc.subject.keyword | 胃癌細胞,DHA,EPA,巨噬細胞,轉移,基質金屬蛋白酶, | zh_TW |
dc.subject.keyword | gastric cancer,DHA,EPA,macrophage,migration,matrix metalloproteinase, | en |
dc.relation.page | 42 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2012-01-11 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 1.58 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。